Journal article
Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda
JCO oncology practice, Vol.21(6), pp.801-812
06/2025
DOI: 10.1200/OP.24.00364
PMCID: PMC12667017
PMID: 39642333
Abstract
Lymphomas are a heterogeneous group of diseases that develop in individuals of all ages and have variable prognoses. Improved survival resulting from therapy advances has led to the emergence of diverse late effects. Although several (US)-based organizations have developed survivorship guidelines, the distinct features of lymphoma subtypes and diverse therapies used raise concerns regarding their applicability to lymphoma survivors. We compared survivorship recommendations (outside primary disease monitoring) between US clinical guidelines.
We extracted information from 17 guidelines from five US-based organizations: ASCO (n = 11), American Cancer Society (n = 1), Children's Oncology Group (n = 1), Center for International Blood and Marrow Transplant Research (n = 1), and the National Comprehensive Cancer Network (n = 3). Guidelines were evaluated to determine whether they offer recommendations on
,
(
), and
. Comparisons were focused on second primary malignancy, cardiovascular complications, and vaccination.
Survivorship recommendations on
and
mainly differ in the timing and approaches for screening. Vaccination recommendations were primarily derived from other cancer populations. Identified research gaps were a lack of understanding of the risk of late effects across lymphoma subtypes, the role of social determinants of health in survivorship, and the lack of a survivorship care model that integrates lymphoma subtypes and treatment exposures.
This study raises awareness about the complexity and challenges of managing survivors under the umbrella diagnosis of lymphoma. The inconsistency and incompleteness of existing guidelines may lead to suboptimal survivorship care. We propose expert-based research priorities to address gaps and unmet needs to help develop risk-based follow-up recommendations to optimize survivorship care for lymphoma survivors.
Details
- Title: Subtitle
- Comparison of Survivorship Care Guidelines for Patients With Lymphoma: Recommendations for Harmonization and Future Research Agenda
- Creators
- Bryan ValcarcelKerry J SavageBrian K LinkJohn P LeonardKara M KellyGita ThanarajasingamJames R CerhanBarbara ProLeo I GordonCarrie A ThompsonSonali M SmithLindsay M Morton
- Resource Type
- Journal article
- Publication Details
- JCO oncology practice, Vol.21(6), pp.801-812
- DOI
- 10.1200/OP.24.00364
- PMID
- 39642333
- PMCID
- PMC12667017
- NLM abbreviation
- JCO Oncol Pract
- ISSN
- 2688-1527
- eISSN
- 2688-1535
- Publisher
- LIPPINCOTT WILLIAMS & WILKINS
- Grant note
- e Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, National Institutes of Health, Bethesda, MD
Supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics of the National Cancer Institute, National Institutes of Health, Bethesda, MD.
- Language
- English
- Electronic publication date
- 12/06/2024
- Date published
- 06/2025
- Academic Unit
- Hematology, Oncology, and Blood & Marrow Transplantation; Epidemiology; Internal Medicine
- Record Identifier
- 9984756245302771
Metrics
2 Record Views